Sonic hedgehog signaling in kidney fibrosis: a master communicator

作     者：Dong Zhou Roderick J.Tan Youhua Liu 

作者机构：Department of Pathology University of Pittsburgh School of Medicine Department of Medicine University of Pittsburgh School of Medicine State Key Laboratory of Organ Failure Research National Clinical Research Center of Kidney Disease Nanfang Hospital Southern Medical University 

出 版 物：《Science China(Life Sciences)》 (中国科学（生命科学英文版）)

年 卷 期：2016年第59卷第9期

页      面：920-929页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

基　　金：supported by the National Natural Science Foundation of China(81130011,81370839,81521003) Guangdong Science Foundation(2014A030312014) Guangzhou Projects Grant(15020025) American Heart Association FTF(16990086) National Institutes of Health Grants(DK064005,DK091239,DK106049) 

主　　题：Sonic hedgehog Gli tubular cells fibroblast renal fibrosis 

摘      要：The hedgehog signaling cascade is an evolutionarily conserved pathway that regulates multiple aspects of embryonic development and plays a decisive role in tissue homeostasis. As the best studied member of three hedgehog ligands, sonic hedgehog(Shh) is known to be associated with kidney development and tissue repair after various insults. Recent studies uncover an intrinsic link between dysregulated Shh signaling and renal fibrogenesis. In various types of chronic kidney disease(CKD), Shh is upregulated specifically in renal tubular epithelium but targets interstitial fibroblasts, thereby mediating a dynamic epithelialmesenchymal communication(EMC). Tubule-derived Shh acts as a growth factor for interstitial fibroblasts and controls a hierarchy of fibrosis-related genes, which lead to the excessive deposition of extracellular matrix in renal interstitium. In this review, we recapitulate the principle of Shh signaling, its activation and regulation in a variety of kidney diseases. We also discuss the potential mechanisms by which Shh promotes renal fibrosis and assess the efficacy of blocking this signaling in preclinical settings. Continuing these lines of investigations will provide novel opportunities for designing effective therapies to improve CKD prognosis in patients.